Page 4 - Chris Meduri News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Anteris Technologies Ltd unveils encouraging FIH results from DurAVR™ heart valve study

Galvanised by results from its DurAVR™ transcatheter heart valve’s first-in-human study, Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) has presented its.

Chris meduriSusheel kodaliAnteris technologies ltd

Anteris Technologies Ltd delivers strong 12-month results from DurAVR™ FIH study

Anteris Technologies Ltd delivers strong 12-month results from DurAVR™ FIH study
proactiveinvestors.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com.au Daily Mail and Mail on Sunday newspapers.

United statesChris meduriWayne patersonAnteris technologies ltdHeart valveEffective orifice area

Anteris Technologies Ltd higher as DurAVR™ transcatheter heart valve system receives FDA tick for early feasibility study

Anteris Technologies Ltd higher as DurAVR™ transcatheter heart valve system receives FDA tick for early feasibility study
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesCity ofUnited kingdomChris meduriMichael reardonWayne patersonDepartment of cardiovascular surgeryAnteris technologies ltdCardiovascular researchAnteris teamDrug administrationAllison familyCardiovascular surgeryHouston methodist hospitalFirst in human studyTranscatheter cardiovascular therapeutics

Anteris Technologies Ltd preliminary results show restoration of pre-disease blood flow compared to competing technologies

When current generation competing valve technologies were compared to the healthy aortic valve, they demonstrated statistically significant.

United statesAnteri durChris meduriWayne patersonAnteris technologies ltdTranscatheter cardiovascular therapeuticsTechnologies ltd

Anteris Technologies Announces Presentation of First-In-Human Data for its Novel TAVR Product, DurAVR™ at the 2022 Annual TCT Congress in Boston

Anteris Technologies Announces Presentation of First-In-Human Data for its Novel TAVR Product, DurAVR™ at the 2022 Annual TCT Congress in Boston
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPaul sorajjaSusheel kodaliChris meduriWayne patersonAnteri durDejan torackiVinayakn bapatAnita asgarSamir kapadiaVinayak bapatForum fromDr van miegham erasmus universityAnteris technologies ltdStructural heart valve center at newyorkMinneapolis heart institute